文献速递瓣膜外科

二尖瓣环分离患者二尖瓣修复术的结局

Outcomes of patients with mitral annular disjunction undergoing mitral valve repair†.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

本研究回顾性纳入2021至2023年单中心326例因二尖瓣脱垂接受二尖瓣修复术的患者,按是否存在二尖瓣环分离分组,倾向性评分1:1匹配后各50例。匹配后两组院内死亡率均为0%,早期再手术率及残余反流≥2或主要房性/室性心律失常无显著差异,但MAD组需要延长正性肌力药物和机械循环支持(IABP/ECMO)的比例更高(0% vs 10%,P=0.050)。中期随访复合结局两组相似。

要点

  • MAD患者行二尖瓣修复术后早期需延长正性肌力药物及机械循环支持的比例更高(0% vs 10%,P=0.050)。
  • 匹配后两组院内死亡率均为0%,早期再手术率均为0%,残余反流≥2及主要心律失常无显著差异。
  • 中期随访复合结局两组相似,生存无差异。

核心结论

  • 二尖瓣环分离患者行二尖瓣修复术与更高的早期左心室功能障碍需机械支持发生率相关,但随访生存无差异。

研究设计与样本

  • 回顾性单中心研究,纳入2021至2023年连续326例因二尖瓣脱垂行二尖瓣修复术的患者,按MAD存在与否分组,倾向性评分1:1匹配后各50例。

主要发现

  • 匹配后两组术前特征无显著差异,院内死亡率均为0%。
  • 早期再手术率均为0%,残余二尖瓣反流≥2或主要房性/室性心律失常无显著差异。
  • MAD组需要延长正性肌力药物和机械循环支持(IABP/ECMO)的比例为10%,无MAD组为0%(P=0.050)。
  • 中期随访复合结局两组相似。

关键数值与推荐

  • 主要终点包括院内生存和修复早期失败。
  • 复合次要终点包括主要不良心脏事件(MACEs):再手术、残余反流≥2、术后严重左心室功能障碍需延长(>3天)正性肌力支持、心律失常及总生存。

临床怎么用

  • 对合并MAD的二尖瓣脱垂患者行二尖瓣修复术时,应警惕术后早期左心室功能障碍需机械循环支持的风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Mitral annular disjunction (MAD) is an abnormal displacement of the posterior mitral leaflet into the left atrial wall, potentially leading to left ventricular dysfunction, malignant ventricular arrhythmias (VA) and sudden cardiac death. This study investigates the outcomes of patients with and without MAD undergoing mitral valve repair for valve prolapse (MVP). METHODS: The study retrospectively collected a single-center experience from 2021 to 2023 on 326 consecutive patients undergoing mitral valve repair for MVP. Patients were divided into two groups according to the presence of MAD. After propensity score matching 1:1, two comparable groups of 50 patients were obtained. Primary endpoints included hospital survival and early failure of the repair. Composite secondary endpoint included major adverse cardiac events (MACEs) such as reoperation, residual regurgitation ≥2, severe postoperative left ventricle (LV) dysfunction requiring prolonged (>3 days) inotropic support, cardiac arrhythmias and overall survival. RESULTS: After matching, there were no significant differences between the groups in terms of preoperative characteristics. Hospital mortality was 0% in both groups, and there were no significant differences in terms of early reoperation (0%) or residual mitral regurgitation ≥2 or major atrial/VA. Nevertheless, patients with MAD presented a greater need for prolonged inotropic and mechanical circulatory support (IABP/ECMO): No-MAD 0% vs MAD 10% (P = 0.050). However, the composite outcome at midterm follow-up was similar between the groups. CONCLUSIONS: Mitral valve repair in patients with MAD was associated with a significantly higher incidence of early LV dysfunction requiring mechanical support. However, no difference was found in terms of survival at follow-up.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Muneretto C, D'Alonzo M, Baudo M, et al. Outcomes of patients with mitral annular disjunction undergoing mitral valve repair†. Eur J Cardiothorac Surg. 2025. PMID: 39891398. doi:10.1093/ejcts/ezaf029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。